BioCentury | Feb 10, 2014
Company News

Xenetic Biosciences Inc, Baxter deal

...The partners amended a 2005 deal under which Xenetic (formerly Lipoxen plc ) granted Baxter exclusive rights...
BioCentury | Dec 9, 2013
Clinical News

PSA-Oxyntomodulin: Phase I started

...I trial to evaluate 3 dose levels of PSA-Oxyntomodulin in 12 healthy volunteers. Xenetic (formerly Lipoxen plc...
BioCentury | Dec 9, 2013
Clinical News

PulmoXen: Phase I started

...trial to evaluate 2,500 and 5,000 units of PulmoXen in 12 healthy volunteers. Xenetic (formerly Lipoxen plc...
BioCentury | May 6, 2013
Company News

Opko, Pharmsynthez deal

...and PulmoXen outside of Russia under a November 2009 deal. Xenetic was formerly known as Lipoxen plc...
BioCentury | Dec 3, 2012
Clinical News

MyeloXen: Phase I/IIa started

...in the third part. Pharmsynthez has exclusive rights to MyeloXen in Russia, while Xenetic (formerly Lipoxen plc...
BioCentury | Jan 30, 2012
Company News

Xenetic Biosciences, Serum Institute of India deal

...under the deal, including a preclinical 13 valent pneumococcal vaccine and StimuXen . Xenetic (formerly Lipoxen plc...
BioCentury | Jan 23, 2012
Company News

SymbioTec, Xenetic Biosciences deal

...Xenetic (formerly Lipoxen plc ) completed its acquisition of cancer company SymbioTec. SymbioTec shareholders received 80 million...
BioCentury | Dec 19, 2011
Company News

Xenetic, SymbioTec deal

...Xenetic, formerly Lipoxen plc , had expected to complete the acquisition by Dec. 15. In July, Lipoxen...
BioCentury | Nov 30, 2011
Financial News

Xenetic raises $19M in placing

...close of 9.25p on Aug. 3, the day before the offering was announced. Xenetic (formerly Lipoxen plc...
BioCentury | Aug 8, 2011
Company News

Lipoxen, SymbioTec deal

...will acquire cancer company SymbioTec in a stock deal valued at £8.8 million ($14.5 million). Lipoxen...
...acute myelogenous leukemia (AML). Lipoxen plans to change its name to Xenetic Biosciences plc . Lipoxen plc...
Items per page:
1 - 10 of 50
BioCentury | Feb 10, 2014
Company News

Xenetic Biosciences Inc, Baxter deal

...The partners amended a 2005 deal under which Xenetic (formerly Lipoxen plc ) granted Baxter exclusive rights...
BioCentury | Dec 9, 2013
Clinical News

PSA-Oxyntomodulin: Phase I started

...I trial to evaluate 3 dose levels of PSA-Oxyntomodulin in 12 healthy volunteers. Xenetic (formerly Lipoxen plc...
BioCentury | Dec 9, 2013
Clinical News

PulmoXen: Phase I started

...trial to evaluate 2,500 and 5,000 units of PulmoXen in 12 healthy volunteers. Xenetic (formerly Lipoxen plc...
BioCentury | May 6, 2013
Company News

Opko, Pharmsynthez deal

...and PulmoXen outside of Russia under a November 2009 deal. Xenetic was formerly known as Lipoxen plc...
BioCentury | Dec 3, 2012
Clinical News

MyeloXen: Phase I/IIa started

...in the third part. Pharmsynthez has exclusive rights to MyeloXen in Russia, while Xenetic (formerly Lipoxen plc...
BioCentury | Jan 30, 2012
Company News

Xenetic Biosciences, Serum Institute of India deal

...under the deal, including a preclinical 13 valent pneumococcal vaccine and StimuXen . Xenetic (formerly Lipoxen plc...
BioCentury | Jan 23, 2012
Company News

SymbioTec, Xenetic Biosciences deal

...Xenetic (formerly Lipoxen plc ) completed its acquisition of cancer company SymbioTec. SymbioTec shareholders received 80 million...
BioCentury | Dec 19, 2011
Company News

Xenetic, SymbioTec deal

...Xenetic, formerly Lipoxen plc , had expected to complete the acquisition by Dec. 15. In July, Lipoxen...
BioCentury | Nov 30, 2011
Financial News

Xenetic raises $19M in placing

...close of 9.25p on Aug. 3, the day before the offering was announced. Xenetic (formerly Lipoxen plc...
BioCentury | Aug 8, 2011
Company News

Lipoxen, SymbioTec deal

...will acquire cancer company SymbioTec in a stock deal valued at £8.8 million ($14.5 million). Lipoxen...
...acute myelogenous leukemia (AML). Lipoxen plans to change its name to Xenetic Biosciences plc . Lipoxen plc...
Items per page:
1 - 10 of 50